W J Elliott

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. doi request reprint Calcium channel blockers
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Chicago, IL, USA
    J Clin Hypertens (Greenwich) 13:687-9. 2011
  2. ncbi request reprint Optimizing medication adherence in older persons with hypertension
    William J Elliott
    The Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Int Urol Nephrol 35:557-62. 2003
  3. ncbi request reprint Management of hypertension in the very elderly patient
    William J Elliott
    Department of Preventive Medicine, Rush University Medical Center, 1700 W Van Buren, Suite 470, Chicago, IL 60612, USA
    Hypertension 44:800-4. 2004
  4. ncbi request reprint Prehypertension
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
    Nat Clin Pract Cardiovasc Med 4:538-48. 2007
  5. ncbi request reprint The role of calcium antagonists in stroke prevention
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:5-8. 2005
  6. ncbi request reprint Differential effects of antihypertensive drugs on new-onset diabetes?
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Curr Hypertens Rep 7:249-56. 2005
  7. ncbi request reprint Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:2-4. 2005
  8. ncbi request reprint A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:654-63. 2005
  9. ncbi request reprint Clinical features in the management of selected hypertensive emergencies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    Prog Cardiovasc Dis 48:316-25. 2006
  10. ncbi request reprint Drug interactions and drugs that affect blood pressure
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 8:731-7. 2006

Detail Information

Publications47

  1. doi request reprint Calcium channel blockers
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Chicago, IL, USA
    J Clin Hypertens (Greenwich) 13:687-9. 2011
    ..Diltiazem and verapamil have important drug interaction with digoxin and cyclosporine, among others...
  2. ncbi request reprint Optimizing medication adherence in older persons with hypertension
    William J Elliott
    The Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Int Urol Nephrol 35:557-62. 2003
    ..Improving medication adherence would be a simple way to make antihypertensive therapies much more cost effective, since a medication that is not taken incurs all of cost, and provides no benefit to the patient...
  3. ncbi request reprint Management of hypertension in the very elderly patient
    William J Elliott
    Department of Preventive Medicine, Rush University Medical Center, 1700 W Van Buren, Suite 470, Chicago, IL 60612, USA
    Hypertension 44:800-4. 2004
    ..Its choice of a diuretic as initial therapy is consistent with other trials, but chlorthalidone is the drug with the most compelling evidence in large US trials that included very elderly patients...
  4. ncbi request reprint Prehypertension
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
    Nat Clin Pract Cardiovasc Med 4:538-48. 2007
    ..In this Review, we attempt to summarize the recently published data concerning the epidemiology, attendant risks and potential treatment options for this important and growing public-health problem...
  5. ncbi request reprint The role of calcium antagonists in stroke prevention
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:5-8. 2005
    ..The risk of heart failure, however, is significantly increased (by 29%) with the initial calcium antagonist. These estimates may change as newer trials are reported...
  6. ncbi request reprint Differential effects of antihypertensive drugs on new-onset diabetes?
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Curr Hypertens Rep 7:249-56. 2005
    ..An earlier diagnosis of diabetes mellitus generally has little impact (over 5 years) on cardiovascular risk. The clinical importance of differential effects of antihypertensive drugs on incident diabetes is, therefore, much less clear...
  7. ncbi request reprint Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:2-4. 2005
    ..Although angiotensin-converting enzyme inhibitors can cause cough and angioedema (more common among blacks), angiotensin receptor blockers are currently more expensive and have fewer outcome trials to support their use...
  8. ncbi request reprint A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:654-63. 2005
    ....
  9. ncbi request reprint Clinical features in the management of selected hypertensive emergencies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    Prog Cardiovasc Dis 48:316-25. 2006
    ..Long-term follow-up to ensure adequate control of hypertension is necessary to prevent further target-organ damage and recurrence of another hypertensive emergency...
  10. ncbi request reprint Drug interactions and drugs that affect blood pressure
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 8:731-7. 2006
    ....
  11. ncbi request reprint Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL, USA
    J Am Board Fam Med 20:72-80. 2007
    ..To assess 1-year persistence and adherence with monotherapy using the most commonly dispensed individual agent in 4 antihypertensive drug classes: hydrochlorothiazide (HCTZ), amlodipine, lisinopril, or valsartan...
  12. ncbi request reprint Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Lancet 369:201-7. 2007
    ..We therefore undertook a network meta-analysis, which accounts for both direct and indirect comparisons to assess the effects of antihypertensive agents on incident diabetes...
  13. ncbi request reprint A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplace
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Chicago, IL 60612, USA
    Blood Press Monit 12:23-8. 2007
    ....
  14. pmc Device-guided breathing to lower blood pressure: case report and clinical overview
    William J Elliott
    Rush Medical College, Chicago, Illinois, USA
    MedGenMed 8:23. 2006
    ..Device-guided paced breathing may offer an effective, simple, and new nonpharmacologic option for treating high BP without additional side effects, but like all lifestyle modifications, must be practiced consistently to provide benefits...
  15. ncbi request reprint Renovascular hypertension: an update
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 10:522-33. 2008
    ....
  16. ncbi request reprint Management of hypertension emergencies
    William J Elliott
    RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 5:486-92. 2003
    ..When properly treated, "malignant hypertension" need be considered malignant no longer...
  17. ncbi request reprint Is fixed combination therapy appropriate for initial hypertension treatment?
    William J Elliott
    Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 4:278-85. 2002
    ....
  18. ncbi request reprint Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers
    W J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 2:402-11. 2000
    ..Many longer-term outcome studies with survival endpoints are under way, but most will compare the combination against an ACE inhibitor alone. These studies will define the optimal use of these agents in medicine for decades to come...
  19. ncbi request reprint Hypertensive emergencies
    W J Elliott
    Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
    Crit Care Clin 17:435-51. 2001
    ..Because of advances in antihypertensive therapy and management, "malignant hypertension" should be truly malignant no longer...
  20. ncbi request reprint Cyclic and circadian variations in cardiovascular events
    W J Elliot
    Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Am J Hypertens 14:291S-295S. 2001
    ..Individuals who work night shifts and those whose BP has a different circadian pattern have a higher risk of cardiovascular events, but may be less likely to have an increased risk of cardiovascular events in the morning...
  21. ncbi request reprint Treatment of hypertension in the elderly
    Warren J Elliott
    Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
    Am J Geriatr Cardiol 11:11-20; quiz 20-2. 2002
    ..Future cardiovascular risk may be related directly to the blood pressure attained, rather than to how it was attained...
  22. ncbi request reprint Timing treatment to the rhythm of disease. A short course in chronotherapeutics
    W J Elliott
    Rush Medical College, Rush University, Chicago, USA
    Postgrad Med 110:119-22, 125-6, 129. 2001
    ..Results of the ongoing CONVINCE study may provide evidence that chronotherapy for hypertension and angina pectoris may be more effective than traditional homeostatic treatment...
  23. ncbi request reprint The economic impact of hypertension
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Rush Presbyterian St Lukes Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 5:3-13. 2003
    ..Pharmacoeconomic analyses regarding antihypertensive drug therapies, their costs, and the relevant reductions in health care expenditures are a useful framework for optimizing current strategies for hypertension management...
  24. ncbi request reprint Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention
    Kenneth L Choi
    Department of Preventive Medicine, Rush Medical College, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 7:367-73. 2005
    ..Therefore, for cardiovascular end points (as opposed to renal end points), it may be more important that the blood pressure is reduced, rather than how the process is started...
  25. ncbi request reprint Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial
    W J Elliott
    Rush-Presbyterian/St Luke's Medical Center, Chicago, Illinois, USA
    Clin Ther 23:1166-79. 2001
    ..Losartan, but not valsartan, was associated with a decrease in serum uric acid levels...
  26. ncbi request reprint One-year study of felodipine or placebo for stage 1 isolated systolic hypertension
    H R Black
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush Presbyterian Saint Luke s Medical Center, Chicago, Illinois, USA
    Hypertension 38:1118-23. 2001
    ..Larger and longer studies will be needed to document any long-term reduction in cardiovascular event rates associated with treating stage 1 systolic hypertension...
  27. ncbi request reprint Circadian variation in blood pressure: implications for the elderly patient
    W J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University and Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA
    Am J Hypertens 12:43S-49S. 1999
    ....
  28. ncbi request reprint Detection, treatment, and control of adult hypertension in northwest Indiana. Ispat Inland/United Steelworkers of America Health Care Network
    W J Elliott
    Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612, USA
    Am J Hypertens 12:830-4. 1999
    ....
  29. ncbi request reprint Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region
    Henry R Black
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Hypertens 23:1099-106. 2005
    ..To examine regional differences in the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial...
  30. ncbi request reprint What factors contribute to the inadequate control of elevated blood pressure?
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612 3244, USA
    J Clin Hypertens (Greenwich) 10:20-6. 2008
    ..Single-pill, or fixed-dose, combination therapy is one approach that improves adherence, while also providing the antihypertensive efficacy needed to help patients achieve their blood pressure goals...
  31. ncbi request reprint Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
    Henry R Black
    Rush Medical College of Rush University, Chicago, IL 60612, USA
    JAMA 289:2073-82. 2003
    ..Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial...
  32. ncbi request reprint Hypertension in women: the Women Take Heart project
    A lice A Furumoto-Dawson
    Department of Preventive Medicine, Rush Medical College, Rush Presbyterian St Lukes Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 5:38-46. 2003
    ..1% of self-reported hypertensives. Results from this study and national surveys indicate that hypertension detection and control remain major public health challenges in preventing cardiovascular disease in older women...
  33. ncbi request reprint Clinical features and management of selected hypertensive emergencies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 6:587-92. 2004
    ..Because of advances in antihypertensive therapy and management, "malignant hypertension" should be malignant no longer...
  34. ncbi request reprint Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
    Nitin Khosla
    Department of Preventive Medicine, Rush Hypertension Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:354-6. 2005
  35. ncbi request reprint Resistant hypertension revisited: a comparison of two university-based cohorts
    Jay P Garg
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, 60612, USA
    Am J Hypertens 18:619-26. 2005
    ..To assess whether the reasons for and treatment of RH have changed, we determined the frequency of various causes of resistance, the proportion of patients achieving goal BP, and the changes made in antihypertensive regimens...
  36. ncbi request reprint Systemic hypertension
    William J Elliott
    Rush Medical College, Rush University Medical Center, Chicago, USA
    Curr Probl Cardiol 32:201-59. 2007
    ..Special circumstances exist for treatment of hypertension in pregnancy, in childhood, in the elderly, and in both extremes of blood pressure (pre-hypertension or hypertensive emergencies)...
  37. ncbi request reprint Compliance--and improving it--in hypertension
    William J Elliott
    Rush Medical College, Chicago, USA
    Manag Care 12:56-61. 2003
    ..Compliance and persistence rates vary by drug class, but clinicians can take practical steps to improve patient adherence to any prescribed regimen. JNC-7 recognizes barriers to physician compliance with treatment recommendations...
  38. pmc Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment
    Michael L Maitland
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    Clin Cancer Res 15:6250-7. 2009
    ..This prospective, single-center, cohort study characterized ambulatory blood pressure monitoring as an early pharmacodynamic biomarker of VEGF signaling pathway inhibition by sorafenib...
  39. doi request reprint Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy
    William J Elliott
    Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 11:376-82. 2009
    ..More widespread use of such agents, particularly those available in generic formulations or in low-cost formularies, may lead to better long-term BP control and fewer cardiovascular events...
  40. ncbi request reprint Blood pressure reduction is not the only determinant of outcome
    Peter S Sever
    International Centre for Circulatory Health, Imperial College London, 59 N Wharf Rd, London, W2 1PG, UK
    Circulation 113:2754-72; discussion 2773-4. 2006
  41. ncbi request reprint Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR
    Franz Messerli
    Department of Medicine, Division of Cardiology, St Luke s Roosevelt Hospital and Columbia University, New York, NY, USA
    Blood Press Suppl 1:6-9. 2007
    ..Despite differences in the risk profiles of previously studied patients and INVEST patients, the antihypertensive effects of Ve+Tr were similar...
  42. ncbi request reprint Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study
    Jay P Garg
    Division of Nephrology, Department of Medicine, University of California San Francisco, USA
    Am J Nephrol 25:393-9. 2005
    ..Because angiotensin II may have adverse effects on the arterial wall, we hypothesized that an angiotensin receptor blocker (ARB) would improve arterial compliance as compared with placebo in subjects with CKD...
  43. ncbi request reprint Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation
    Thomas J Hogan
    MEDTECH, Morristown, New Jersey 07960, USA
    Pharmacoeconomics 20:37-47. 2002
    ..To conduct an economic analysis in the US of antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency...
  44. ncbi request reprint Chlorthalidone vs other low-dose diuretics
    Kenneth L Choi
    JAMA 292:1816-7; author reply 1817. 2004
  45. ncbi request reprint Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements
    Joel M Neutel
    Orange County Heart Institute and Research Center, Orange, CA 92868, USA
    J Clin Hypertens (Greenwich) 4:325-31. 2002
    ..The safety profile of olmesartan medoxomil was similar to that of placebo. Olmesartan medoxomil appears to be a safe and effective once-a-day treatment for hypertension...
  46. ncbi request reprint How pharmacists can assist physicians with controlling blood pressure
    Barry L Carter
    Department of Family Medicine, Colleges of Pharmacy and Medicine, University of Iowa, Iowa City, IA 52242, USA
    J Clin Hypertens (Greenwich) 5:31-7. 2003
    ..This review summarizes studies involving pharmacist participation in hypertension management and provides recommendations for obtaining pharmacist involvement...
  47. ncbi request reprint Drug delivery systems for treatment of systemic hypertension
    L Michael Prisant
    Hypertension and Clinical Pharmacology Unit, Medical College of Georgia, Augusta, Georgia 30912, USA
    Clin Pharmacokinet 42:931-40. 2003
    ..Potential advantages include reduced administration frequency, enhanced adherence and convenience, reduced toxicity, stable drug concentrations, uniform drug effect, decreased cost (occasionally) and decreased daily dosage...